2021 ASCO Annual Meeting Auditors All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Name Employment Leadership Stock and Other Honoraria Consulting or Advisory Speakers' Bureau Research Funding Patents, Royalties, Expert Testimony Travel, Other Relationship (OPTIONAL) (OPTIONAL) Open Ownership Interests Role Other Intellectual Accommodations, Uncompensated Payments Link Property Expenses Relationships Patrick Burke Lilly (I), Eisai (I) Novartis (Inst), Takeda (Inst) Sham Mailankody Physician Education Juno Therapeutics (Inst), Resource, Plexus Takeda (Inst), Janssen Oncology (Inst), Allogene (Inst), Bristol-Myers Squibb (Inst)
Lisa Law Mary Cianfrocca Roche/Genentech Roche/Genentech Brian O'Sullivan IBA, Merck, Pfizer Erica Stringer-Reasor Breast Cancer Index, Lilly, Immunomedics, Novartis, Lilly Susan G. Komen for the Cascadian Therapeutics, Genentech https://openpayments Mylan Lilly, OncoSec Cure, V Foundation Lilly data.cms.gov/physician /974630 Rodabe Amaria Iovance Biotherapeutics, Merck (Inst), Bristol-Myers Nektar, Novartis Squibb (Inst), Novartis (Inst), Array BioPharma (Inst), Genentech (Inst), Iovance Biotherapeutics (Inst)
Julia White Intraop Medical (Inst) Fabrice Andre Pegacsy AstraZeneca (Inst), Novartis, Roche, Novartis (Inst), Pfizer GlaxoSmithKline, (Inst), Lilly (Inst), Roche AstraZeneca (Inst), Daiichi (Inst) Kunal Kadakia Kathleen Moore Research To Practice, Genentech/Roche, PTC Therapeutics (Inst), Prime Oncology, Physician Immunogen, AstraZeneca Lilly (Inst), Merck (Inst), Education Resource (Inst), Tesaro (Inst), VBL Tesaro (Inst), Genentech Therapeutics, Merck, (Inst), Clovis Oncology Aravive, Pfizer/EMD (Inst), Lilly Foundation Serono, Eisai, Abbvie, (Inst), Regeneron (Inst), Vavotar, Mersana (Inst), Advaxis (Inst), Bristol- Myriad Genetics Myers Squibb (Inst), Verastem (Inst), Novartis Pharmaceuticals UK (Inst), AstraZeneca (Inst), Agenus (Inst), Takeda (Inst), Forty Seven (Inst), Immunogen (Inst), Bayer (Inst), Novogen (Inst), Abbvie/Stemcentrx (Inst)
Leslie Ballas University of Southern California Keck School of Medicine Benedito Carneiro Tempus, EMD Serono, Abbvie (Inst), Pfizer (Inst), Foundation Medicine Bayer (Inst), AstraZeneca/ MedImmune (Inst), Astellas Pharma (Inst), Actuate Therapeutics (Inst)
Walid Shaib Ipsen, Lexicon, Bristol- ArQule (Inst), Lilly (Inst), Lexicon Myers Squibb, Blueprint Basilea (Inst), Lexicon Medicines, Natter, Mylan (Inst)
Ishmael Jaiyesimi Edgardo Santos Genentech/Roche, Pfizer, Amgen, Boehringer Ingelheim, Merck, Novartis, AstraZeneca, Takeda, Sanofi Genzyme, Lilly, Astellas Pharma, G1 Therapeutics
Ryan Gentzler Jimmy Ruiz AstraZeneca AstraZeneca, Genentech AstraZeneca (Inst), Roche AstraZeneca, (Inst), BeyondSpring Genentech/Roche Pharmaceuticals (Inst), ER Squibb
Andrew McKenzie Andrew Seidman Genomic Health, Eisai, Genentech/Roche, Eisai, Genomic Health, Eisai, Bayer, Odonate Lilly, Genentech/Roche, Novartis, Lilly, Odonate Genentech/Roche, Lilly, Therapeutics (Inst), Nektar Novartis, AstraZeneca, Therapeutics, Novartis/Pfizer, (Inst) Immunomedics BeyondSpring Genentech/Roche, Pharmaceuticals, Pfizer, AstraZeneca/ MedImmune Immunomedics Don Dizon InfiniteMD, NeuHope i-Mab, Clovis Oncology, Merck Sharp & Dohme https://openpayments AstraZeneca, Regeneron, (Inst), Bristol-Myers data.cms.gov/physician Tesaro Squibb (Inst), Kazia Pharmaceuticals (Inst), /744193/summary Tesaro (Inst) Emily Slotkin Eli Lilly and Company (Inst) Ignacio Garrido-Laguna Array BioPharma, Eisai Novartis (Inst), Ignyta (Inst), Halozyme (Inst), Bayer (Inst), Bristol-Myers Squibb (Inst), Pfizer (Inst), MedImmune (Inst), Lilly (Inst), Incyte (Inst), GlaxoSmithKline (Inst), ARMO BioSciences (Inst), Tolero Pharmaceuticals (Inst), BridgeBio Pharma (Inst), Jacobio (Inst)
Saad Usmani Celgene, Amgen, Janssen Celgene, Takeda, Amgen, Celgene, Array Oncology, Seattle Janssen Oncology, Sanofi BioPharma, Janssen Genetics, Takeda, Oncology, Pharmacyclics, GlaxoSmithKline, Sanofi, Bristol-Myers Karyopharm Therapeutics, Squibb, Amgen, Seattle Abbvie, SkylineDX, Merck, Genetics, Merck, Skyline Oncopeptides Diagnostics, GlaxoSmithKline
Shilpa Gupta Nektar AstraZeneca, Exelixis, Bristol-Myers Squibb, Merck, Pfizer, Bristol- Bristol-Myers Squibb, Janssen Oncology, Myers Squibb, Seattle Merck Sharp & Dohme, Exelixis Genetics Seattle Genetics Rachel Grisham Mateon Therapeutics, Context Therapeutics EMD Serono Prime Oncology, MCM Verastem Clovis Oncology, (Inst) Education, OncLive, Regeneron, Aptiude Health GlaxoSmithKline Dax Kurbegov HCA Healthcare Bristol-Myers Squibb Novartis, Seattle Genetics, Varian Medical Systems, Lilly Amanda Walker AstraZeneca, Reflexion AstraZeneca Medical, RadImmune Simon Lo Elekta (Inst) Gregory Cote PharmaMar, Epizyme, C4 Macrogenics (Inst), PharmaMar Therapeutics Boston Biomedical (Inst), PharmaMar (Inst), Epizyme (Inst), Agios (Inst), Eisai (Inst), Merck KGaA (Inst), Plexxikon (Inst), CBA (Inst), Bavarian Nordic, Bayer (Inst), Springworks Therapeutics (Inst)
Ajay Nooka Amgen, Janssen Amgen (Inst), Janssen GlaxoSmithKline Oncology, Celgene, Bristol- Oncology (Inst), Takeda Myers Squibb, (Inst) GlaxoSmithKline, Takeda, Oncopeptides, Karyopharm Therapeutics, Adaptive Biotechnologies, Genzyme
Mohamed Salem Taiho Pharmaceutical, Genentech/Roche, Taiho Exelixis, Bristol-Myers Pharmaceutical Squibb Marina Garassino MSD Oncology, Bristol-Myers Squibb, AstraZeneca, Takeda, Bristol-Myers Squibb Pfizer, Roche, AstraZeneca/ MSD, AstraZeneca, MSD Oncology, Celgene, (Inst), MSD (Inst), AstraZeneca MedImmune, Novartis, Takeda, Roche, Incyte, Roche, Bristol- Roche/Genentech (Inst), GlaxoSmithKline, Takeda, Tiziana Life Sciences, Myers Squibb, Otsuka, Eli AstraZeneca/ MedImmune Roche, Bristol-Myers Sanofi/Aventis, Celgene, Lilly (Inst), AstraZeneca (Inst), Squibb Daiichi Sankyo, Inivata, Pfizer (Inst), Incyte, Pfizer, Seattle GlaxoSmithKline (Inst), Genetics, Eli Lilly, Novartis (Inst), Merck GlaxoSmithKline, Bayer (Inst), Incyte (Inst), Takeda Healthcare (Inst), Spectrum Pharmaceuticals, Blueprint Pharmaceuticals (Inst), Medicines, Janssen, Blueprint Medicines (Inst), Regeneron Eli Lilly (Inst), Ipsen (Inst), Janssen (Inst), Exelixis (Inst), MedImmune (Inst), Sanofi (Inst), Pfizer (Inst), Amgen (Inst)
Michael Sabel Watermark Research Breast Cancer Ally and Partners Melanoma Ally mobile technologies Edward Garon Dracen, EMD Serono, Merck (Inst), Genentech Novartis, GlaxoSmithKline, (Inst), AstraZeneca (Inst), Merck, Boehringer Novartis (Inst), Lilly (Inst), Ingelheim, Shionogi, Eisai, Bristol-Myers Squibb Bristol-Myers Squibb, ABL (Inst), Mirati Therapeutics Bio, Sanofi, Xilio (Inst), Dynavax (Inst), Iovance Biotherapeutics (Inst), Neon Therapeutics (Inst), EMD Serono (Inst)
Mairead McNamara Novartis Ipsen, Shire, Sirtex NuCana BioMed NuCana BioMed, Ipsen, Bayer, Novartis Medical, Incyte Servier Bradley Carthon Eisai, Bristol-Myers Squibb Alkermes (Inst), Bristol-Myers Squibb Foundation, MedImmune (Inst), Merck Immunomedics (Inst) Suparna Wedam Joanne Jeter Pfizer, Array BioPharma Merck, Bristol-Myers Pfizer, Array BioPharma Squibb (Inst) Shadia Jalal Adaptimmune AstraZeneca/ MedImmune, Tesaro, Astex Pharmaceuticals Milos Miljkovic Maura Gillison Bristol-Myers Squibb, Bristol-Myers Squibb Merck, EMD Serono, (Inst), Genocea Roche, Kura, BioNTech, Biosciences (Inst), Shattuck, Bayer, Cullinan (Inst) Debiopharm Group, Ipsen, Gilead Sciences, Bicara Therapeutics, BioNTech AG
Ezra Cohen Bayer, MSD, Merck, Regeneron, BioNTech, Eisai, Gilead Gina D'Amato Blueprint Medicines, Epiz, Deciphera, Daiichi Sankyo/Lilly Efrat Dotan Pfizer, Boston Medical ARMO BioSciences Pfizer (Inst), Bayer (Inst), Incyte (Inst), Boston Biomedical (Inst), Merck (Inst), MedImmune (Inst), GlaxoSmithKline (Inst), Lilly (Inst), AstraZeneca (Inst)
Ramon Andrade de Mello AstraZeneca, Novartis, Pfizer, Zodiac, MSD AstraZeneca Amgen, Roche, Merck, Astellas Pharma, Merck Oncology Pierre Fabre, Serono, Eurofarma AstraZeneca, Bristol- Myers Squibb Brazil, Astellas Pharma William Kelly Janssen Oncology, Bayer Merck Sharp & Dohme Sanofi (Inst), Novartis Janssen Oncology, Merck (Inst), Janssen Oncology Sharp & Dohme (Inst), Bayer (Inst), Exelixis (Inst), Seattle Genetics (Inst), Endocyte (Inst), Amgen (Inst), BioClin Therapeutics (Inst), Sarah Cannon Research Institute (Inst), Hoffman-LaRoche (Inst)
James Cleary Bristol-Myers Squibb Merck, Tesaro, Roche, Agios, Bristol- AstraZeneca, Esperas Myers Squibb Pharma, Abbvie (Inst), Merus (Inst), Roche/Genentech (Inst), Bristol-Myers Squibb (Inst)
Cathy Eng Foundation Medicine, Natera, GlaxoSmithKline, Gilead/Forty Seven, Incyte, Mirati Therapeutics
Jeremy Cetnar Gretchen Kimmick Boehringer Ingelheim, Eisai Roche (Inst), Genentech Royalties for Seattle Genetics, Novartis, Eisai, Genomic Health, (Inst), Abraxis BioScience CardioOncology textbook Foundation Medicine Agendia (Inst), Bristol-Myers from Springer, UpToDate Squibb (Inst), Puma Royalties Biotechnology (Inst), Wyeth (Inst), Novartis (Inst), GlaxoSmithKline (Inst), Johnson & Johnson (Inst), Pfizer (Inst)
Ulka Vaishampayan Pfizer, Exelixis, Bayer, Pfizer, Bayer, Exelixis Astellas Pharma, Exelixis, Bristol-Myers Bristol-Myers Squibb, Squibb/Medarex, Merck Merck KGaA Serono, Advanced Accelerator Application, Alkermes, Helsinn Therapeutics Nina J. Karlin Thomas George Tempus Bristol-Myers Squibb https://openpayments (Inst), Merck (Inst), data.cms.gov/physician AstraZeneca/ MedImmune (Inst), Lilly (Inst), Bayer /321938/summary (Inst), Incyte (Inst), Tesaro (Inst), Ipsen (Inst), Seattle Genetics (Inst), Genentech (Inst), Astellas Pharma (Inst) Fatima Cardoso Roche, Novartis, Pfizer, Pfizer, Roche, AstraZeneca, Teva, AstraZeneca Astellas Pharma, Merus, Celgene, Eisai, Daiichi Sankyo, Genentech, Merck Sharp & Dohme, Sanofi, Pierre Fabre, Macrogenics, Amgen, GE Healthcare, GlaxoSmithKline, Mylan, Mundipharma, Seattle Genetics, Samsung Bioepis, Medscape, Prime Oncology
Sam Brondfield Gemini Health, American Physician Institute, IDEO, Doximity, Pharmaceutical Associates
Rachel Buchsbaum “Potent Agelastatin Derivatives as Modulators for Cancer Invasion and Metastasis” Provisional patent application: Docket Number: MITX- 9505/00US 317239-2690 5/13/2017 application in collaboration with Dr. Mohammad Movassaghi (Inst)
Anees Chagpar Protean Biodiagnostics Genomic Health, Lumicell, Puma Biotechnology, Athenex Theodore Laetsch Novartis, Bayer, Loxo, Lilly, Pfizer (Inst), Novartis Cellectis (Inst), Bayer (Inst), Loxo (Inst), Abbvie (Inst), Amgen (Inst), Atara Biotherapeutics (Inst), Bristol-Myers Squibb (Inst), Lilly (Inst), Epizyme (Inst), GlaxoSmithKline (Inst), Janssen (Inst), Jubilant Pharmaceuticals (Inst), Novella Clinical (Inst), Servier (Inst), Foundation Medicine (Inst), Merck Sharp & Dohme (Inst)
Kenneth Grossmann Array BioPharma, Novartis, Bristol-Myers Squibb, Natera Rana McKay Janssen, Novartis, Pfizer (Inst), Bayer (Inst), Tempus, Exelixis, Pfizer, Tempus (Inst) Bristol-Myers Squibb, Astellas Medivation, Dendreon, Bayer, Sanofi, Merck, Vividion, Calithera, AstraZeneca
Thierry Alcindor Novartis Canada Epizyme (Inst), EMD Pharmaceuticals, Lilly, Serono (Inst), Karyopharm Amgen, Taiho Therapeutics (Inst), Pharmaceutical, Eisai, Springworks (Inst), Pfizer/EMD Serono, Astellas Pharma (Inst), Roche Canada, Merck, Deciphera (Inst) Bayer, Bristol-Myers Squibb, AstraZeneca Katherine Thornton More Health, Kilcoyne & Nesbitt Adaptimmune Adaptimmune, Macrogeneics, Deloitte, GlaxoSmithKline Tatiana Prowell Sonali Smith Abbvie/Genentech, TG Celgene, Karyopharm Therapeutics Therapeutics, Bayer, Pharmacyclics/Janssen, Janssen Oncology, Acerta Karyopharm Therapeutics, Pharma/AstraZeneca, Gilead/Forty Seven, Forty Seven, Portola MorphoSys, Bristol-Myers Pharmaceuticals, TG Squibb/Celgene, ADC Therapeutics, Novartis Therapeutics
Chris Hallemeier Imedex, Focus Medical Imdex, Focus Medical Communications Communications Ray Osarogiagbon Lilly, Pfizer, Gilead Biodes Association of Community 2 US and 1 China patents Oncobox Device Cancer Centers (ACCC), for lymph node specimen AstraZeneca, American collection kit and method Cancer Society, Triptych of pathologic evaluation Health Partners
Howard Sandler Radiogel Janssen Caribou Publishing Elizabeth Reed Pfizer Pfizer/NCCN Aref Al-Kali Novartis (Inst), Onconova Therapeutics (Inst), Celgene (Inst), Bristol- Myers Squibb (Inst), Astex Pharmaceuticals (Inst), Ambit Biosciences (Inst), MedImmune (Inst), H3 Biomedicine (Inst), Aprea AB (Inst)
Meredith Giuliani AstraZeneca, Bristol- Myers Squibb Olatunji Alese Ipsen, R-Pharm, Natera, Bristol-Myers Squibb Taiho Oncology, Pfizer, (Inst), Tesaro (Inst), Ipsen QED Therapeutics (Inst), Taiho Pharmaceutical (Inst), Calithera Biosciences (Inst), MabSpace Biosciences (Inst), Corcept Therapeutics (Inst), PCI Biotech (Inst) Roisin Connolly Genentech/Roche (Inst), Pfizer (Inst) Puma Biotechnology (Inst), Novartis (Inst), Merck (Inst), Macrogenics (Inst)
Ana Maria Lopez Christopher Lieu Ipsen Pharmaceuticals Merck (Inst) (Inst), HalioDx (Inst), Pfizer (Inst) Enrique Soto Perez De Celis Roche (I) Jennifer Tseng PeerView PeerView Michelle Kim EpicentRx (Inst), BlueEarth (Inst) Kellie Mathis Syneos Health Sam Lubner Viraj Master Thach-Giao Truong Jochen Lorch Bayer, Eisai, Genentech, Novartis (Inst), Bayer Novartis (Inst), Bristol-Myers Squibb (Inst), Millennium (Inst) Ari Vanderwalde Bristol-Myers Squibb, Amgen (Inst), Merck (Inst), Caris Life Sciences, Genentech/Roche (Inst), Compugen, Concerto Millennium (Inst), Health-AI, Elsevier AstraZeneca (Inst), Polynoma (Inst), Lilly (Inst), Bristol-Myers Squibb (Inst), Amgen (Inst), Replimune (Inst), Caris Life Sciences (Inst), EMD Serono (Inst)
Stewart Fleishman Roselle De Guzman Roche Oncology Roche, Novartis, Centus Biotherapeutics Hospira (Philippines), (Philippines), Boehringer Ingelheim, Roche (Philippines), AstraZeneca, Novartis, AstraZeneca, Zuellig Merck Sharp & Dohme, Merck Serono, MSD Pharma Therapeutics Eisai, Boehringer Oncology, Boehringer Ingelheim, AstraZeneca, Ingelheim Eli Lilly, Novartis
Manali Bhave Wen Wee Ma Wellstat Therapeutics Merrimack (Inst), Athenex (Inst) (Inst), Bristol-Myers Squibb (Inst), Ipsen (Inst), Actuate Therapeutics (Inst), Sun Pharma (Inst), BioMed Valley Discoveries (Inst)
Muhamad Alhaj Moustafa Acrotech Pharma (Inst) Nagla Abdel Karim Abbott Biotherapeutics (I) Immunocore, Amgen Genentech, Bristol-Myers Pfizer, Exelixis, Bristol- Method of Detecting L3B Squibb Myers Squibb/Pfizer Expression in Exosomes
Joseph Curry Rakuten Medical, Sanofi AstraZeneca, Castle Biosciences Travis Osterman Infostratix eHealth, AstraZeneca, GE Healthcare, Microsoft, GE Healthcare Outcomes Insights, IBM Watson Health Biodesix, MD Outlook, GenomOncology, Cota Healthcare, Flagship Biosciences Margaret Macy Johnson & Johnson, GE Ymabs Therapeutics Bayer (Inst), Ignyta (Inst), Patent for non-invasive Healthcare, Varian Medical Roche (Inst), Lilly (Inst), methods of leukemia cell Systems Merck (Inst) detection with MRI/MRS - Patent No. 8894975
Nishant Agrawal